ArticleStudy of Fibro Q Index as a Non invasive Method to Predict Liver Fibrosis in Chronic Hepatitis C
ArticleStudy of Fibro Q Index as a Non invasive Method to Predict Liver Fibrosis in Chronic Hepatitis C
ArticleSerum markers in monitoring the outcome of Sofosbuvir-based treatments in HCV genotype 4 Egyptian patients
ArticleSerum markers in monitoring the outcome of Sofosbuvir-based treatments in HCV genotype 4 Egyptian patients
ArticlePredictors of HCV Response to Treatment with Pegylated Interferon and Ribavirin in Sharkia Governorate
ArticlePredictors of HCV Response to Treatment with Pegylated Interferon and Ribavirin in Sharkia Governorate
ArticleThe relation between interleukin 28B gene polymorphisms (rs8099917 and rs12980275) and the response of treatment of Hepatitis C Virus genotype 4 patients to Sofosbuvir and Daclat
ArticleThe relation between interleukin 28B gene polymorphisms (rs8099917 and rs12980275) and the response of treatment of Hepatitis C Virus genotype 4 patients to Sofosbuvir and Daclat
ArticleA PREDICTIVE AND COMPARATIVE STUDY VIA VIRAL AND BIOCHEMICAL MEASUREMENTS FOR RESPONDERS AND NON-RESPONDERS EGYPTIAN HEPATITIS C PATIENTS TO DACLATASVIR PLUS SOFOSBUVIR THERAPY
ArticleA PREDICTIVE AND COMPARATIVE STUDY VIA VIRAL AND BIOCHEMICAL MEASUREMENTS FOR RESPONDERS AND NON-RESPONDERS EGYPTIAN HEPATITIS C PATIENTS TO DACLATASVIR PLUS SOFOSBUVIR THERAPY
ArticleInterferon-Gamma Inducible Protein-10(IP10) as a Predictor of Early Virologic Response in Chronic Hepatitis C Infected Egyptian Patients Stratified for the Interleukin-28B rs12979860 Genotyp
ArticleInterferon-Gamma Inducible Protein-10(IP10) as a Predictor of Early Virologic Response in Chronic Hepatitis C Infected Egyptian Patients Stratified for the Interleukin-28B rs12979860 Genotyp
ArticleINTERLEUKIN 28B GENE POLYMORPHISMS AS A PREDICTOR OF TREATMENT RESPONSE IN EGYPTIANS WITH CHRONIC HEPATITIS C.
ArticleINTERLEUKIN 28B GENE POLYMORPHISMS AS A PREDICTOR OF TREATMENT RESPONSE IN EGYPTIANS WITH CHRONIC HEPATITIS C.
ArticlePrevalence of Non Organ-Specific Auto Antibodies and its Effect on Response to Antiviral Therapy in Patients with Chronic Hepatitis C Virus Genotype 4
ArticlePrevalence of Non Organ-Specific Auto Antibodies and its Effect on Response to Antiviral Therapy in Patients with Chronic Hepatitis C Virus Genotype 4
ArticleThe outcome of the sofosbuvir Based Therapy in the treatment of Hepatitis C Virus Genotype 4 in Egyptian patients
ArticleThe outcome of the sofosbuvir Based Therapy in the treatment of Hepatitis C Virus Genotype 4 in Egyptian patients